The 101% revenue surge and swing to profitability are transformative, but the 48% bookings decline signals potential revenue deceleration ahead. The strategic alternatives review (investment banker retained) introduces M&A optionality — monitor for a sale process that could crystallize value above current OTC Pink levels. The $5.04M post-quarter MEI order and AMRAAM production increase catalyst add near-term upside, but the bookings drop warrants caution on sustainability.
Price Chart
Executive Summary
Solitron Devices reported a transformative fiscal Q1 2027 with net sales surging 101% YoY to $5.44M and net income of $0.99M ($0.46/share) vs. a ($0.34M) loss a year ago. However, net bookings fell 48% to $1.45M, and the company retained an investment banker to explore strategic alternatives, signaling a potential sale or merger.
Key Financial Metrics
Key Facts
- Net sales increased 101% YoY to $5.44M from $2.70M
- Net income of $0.99M ($0.46/share) vs. net loss of ($0.34M) ($0.16/share) YoY
- Net bookings decreased 48% to $1.45M from $2.80M YoY
- Backlog increased 28% to $23.34M from $18.26M YoY; pro-forma backlog $26.97M including $5.04M post-quarter order
- Gross profit surged to $2.47M from $0.39M; gross margin expanded to ~45.3% from ~14.4%
- Operating income of $1.54M vs. operating loss of ($0.38M) YoY
- Cash and cash equivalents $6.04M vs. $3.91M at prior quarter-end
- Retained investment banker to explore strategic alternatives (sale, merger, or special dividend)
Financial Impact
Net sales doubled to $5.44M (up 101% YoY), net income swung to $0.99M from a ($0.34M) loss, and gross margin expanded from ~14.4% to ~45.3%.
Risk Factors
- Net bookings fell 48% YoY to $1.45M, signaling potential revenue deceleration in coming quarters
- Backlog declined sequentially from $27.28M to $23.34M (excluding post-quarter order)
- Contingent consideration expense of $0.33M related to MEI earn-out may recur
- Strategic alternatives review may not result in any transaction; outcome uncertain
- AMRAAM production increase requires Congressional approval — no guarantee
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-023424 |
| Document: sodi20260708_8k.htm | 0001437749-26-023424 |
| Document: 0001437749-26-023424-index-headers.html | 0001437749-26-023424 |
| Document: 0001437749-26-023424-index.html | 0001437749-26-023424 |
| Document: 0001437749-26-023424.txt | 0001437749-26-023424 |
| 8-K Data (Synthetic) | 0001437749-26-023424 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | 8-K | $37.52 $36.49 | ▼ −2.75% | ▼ −3.20% | $38.09 (+1.52%) |
Aug 14, 2026 10w ago | Insider Cluster | $34.38 $34.75 | ▲ +1.08% | ▲ +2.44% | $38.09 (+10.79%) |
Jul 13, 2026 15w ago | 8-K | $28.19 $29.70 | ▲ +5.36% | ▲ +6.30% | $38.09 (+35.12%) |
Apr 22, 2026 26w ago | 8-K | $27.00 $26.25 | ▼ −2.78% | ▼ −4.26% | $38.09 (+41.07%) |
Apr 7, 2026 29w ago | DEFA14A | $25.85 $27.00 | ▲ +4.45% | ▼ −0.88% | $38.09 (+47.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers